Saudi Arabia Diabetes Market Report & Forecast 2011-2016

Date: April 1, 2011
Pages: 38
Price:
US$ 750.00
License [?]:
Publisher: IMARC Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery
ID: S25513D1335EN
Leaflet:

Download PDF Leaflet

Saudi Arabia Diabetes Market Report & Forecast 2011-2016
IMARC’s new report “Saudi Arabia Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into the Saudi Arabian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup and regional breakup of diabetes in Saudi Arabia. The report has segmented the Saudi Arabian diabetes market into two segments – Insulin and the Oral Antidiabetics market. For each of the aforementioned categories, the report provides historical and future market sales of key classes, key companies, key drugs and key molecules.

The research study serves as an exceptional tool to understand the market trends, therapeutic structure, competitive structure and the outlook of the Saudi Arabian diabetes market till 2016. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Saudi Arabian diabetes market in some form or the other.

Key Questions Answered in this Report:
  • What is the size and demographical breakup of the diabetes population in Saudi Arabia?
  • How has the diabetes market behaved since 2005 and what are the expected trends till 2016?
  • What has been the historical performance of the Saudi Arabian Insulin market during 2005-2010 and its outlook till 2016?
  • What has been the performance of top classes, top players, top molecules and top drugs in the Insulin market during 2005-2010?
  • What has been the historical performance of the Oral Antidiabetics market during 2005-2010 and its outlook till 2016?
  • What has been the performance of top classes, top players, top molecules and top drugs in the Oral Antidiabetics market during 2005-2010?
Why should you buy this report?
  • Gain a deeper understanding on the epidemiology of diabetes in Saudi Arabia and identify your potential patient pool.
  • Analyze the historical, current and future trends in the Insulin and Oral Antidiabetics market to identify potential classes, drugs, partners and competitors for market entry and expansion plans.
  • Develop Investment strategies by identifying companies that have been the biggest winners and losers in the Saudi Arabian Insulin and Oral Antidiabetics market.
  • Gain an insight into future market events such as new product launches.
Classes Covered:

Fast acting Insulins, Long acting Insulins, Intermediate and Fast acting Insulins, Intermediate acting Insulins, Biguanides, Glinides, Sulphonylureas, Glitazones, DPP-IV Inhibitors, Glp-1 Agonists, Alpha-Glucosidase Inhibitors, DPP-IV Inhibitor and Biguanide Combinations, Glitazone and Sulphonylurea Combinations, DPP-IV Inhibitor and Biguanide Antidiabetic Combinations, SGLT Inhibitors, SGLT Inhibitor and Biguanide combinations and all other Oral Antidiabetic classes.

Information Sources:

Information has been sourced from both primary and secondary sources:
  • Primary sources include industry surveys and face to face/telephonic interviews with physicians and industry experts.
  • Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.
Forecasting Methodology:IMARC generates its product and market forecasts utilizing its extensive database of macroeconomic and sector specific data. The initial baseline forecast is generated with the most recent market data. After an initial baseline forecast, all future macroeconomic and sector specific events and assumptions are taken into account to generate the final forecast.
1 RESEARCH METHODOLOGY & MARKET DEFINITIONS

2 EXECUTIVE SUMMARY

3 EPIDEMIOLOGY

3.1 Total Diabetes Patients
3.2 Patients by Gender
3.3 Patients by Age Group
3.4 Patients by Region

4 MARKET DYNAMICS

4.1 Diabetes Market
 4.1.1 Current Trends (2005–2010)
 4.1.2 Market Forecast (2011-2016)
4.2 Insulin Market
 4.2.1 Current Trends (2005-2010)
  4.2.1.1 Market by Class
  4.2.1.2 Market by Molecule
  4.2.1.3 Top Players
  4.2.1.4 Top Drugs
 4.2.2 Forecast (2011-2016)
4.3 Oral Antidiabetics Market
 4.3.1 Current Trends (2005-2010)
  4.3.1.1 Market by Class
  4.3.1.2 Top Players
  4.3.1.3 Top Drugs
 4.3.2 Forecast (2011-2016)

LIST OF FIGURES

Figure 3 1: Saudi Arabia: Number of Diabetes Patients* (in 000’s), 2010, 2015, 2020, 2025 & 2030
Figure 3 2: Saudi Arabia: Breakup of Diabetes Patients* by Gender (in 000’s), 2010, 2015, 2020, 2025 & 2030
Figure 3 3: Saudi Arabia: Breakup of Diabetes Patients* by Gender (in %) 2010, 2015, 2020, 2025 & 2030
Figure 3 4: Saudi Arabia: Breakup of Diabetes Patients* by Age Group (in 000’s), 2010, 2015, 2020, 2025 & 2030
Figure 3 5: Saudi Arabia: Breakup of Diabetes Patients* by Age Group (in %) 2010, 2015, 2020, 2025 & 2030
Figure 3 6: Saudi Arabia: Breakup of Diabetes Patients* by Region (in 000’s), 2010, 2015, 2020, 2025 & 2030
Figure 3 7: Saudi Arabia: Breakup of Number of Patients* by Region, (%) 2010, 2015 & 2020
Figure 4 1: Saudi Arabia: Diabetes Market (in Million US$), 2005-2010
Figure 4 2: Saudi Arabia: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2005-2010
Figure 4 3: Saudi Arabia: Diabetes Market Forecast (in Million US$), 2011-2016
Figure 4 4: Saudi Arabia: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2016
Figure 4 5: Saudi Arabia: Insulin Market (in Million US$), 2005-2010
Figure 4 6: Saudi Arabia: Breakup of Insulin Market by Class (in %), 2005-2010
Figure 4 7: Saudi Arabia: Insulin Market: Share by Molecules (in %), 2005-2010
Figure 4 8: Saudi Arabia: Insulin Market: Share of Key Players (in %), 2005-2010
Figure 4 9: Saudi Arabia: Insulin Market: Share of Key Drugs (in %), 2005-2010
Figure 4 10: Saudi Arabia: Insulin Market Forecast (in Million US$), 2011-2016
Figure 4 11: Saudi Arabia: Oral Antidiabetics Market, (in Million US$), 2005-2010
Figure 4 12: Saudi Arabia: Oral Antidiabetics Market: Share by Class (in %), 2005-2010
Figure 4 13: Saudi Arabia: Oral Antidiabetics Market: Share of Key Players (in %), 2005-2010
Figure 4 14: Saudi Arabia: Oral Antidiabetics Market: Share of Key Drugs (%), 2005-2010
Figure 4 15: Saudi Arabia: Oral Antidiabetics Market Forecast (in Million US$), 2011-2016
Figure 4 16: Saudi Arabia: Oral Antidiabetics Market: Share by Class Forecast (in %),2010, 2013 & 2016

LIST OF TABLES

Table 1 1: Saudi Arabia: Oral Antidiabetics & Insulin Definitions
Table 4 1: Saudi Arabia: Breakup of Insulin Market by Class (in 000 US$), 2005-2010
Table 4 2: Saudi Arabia: Insulin Market: Sales by Molecule (in 000 US$), 2005-2010
Table 4 3: Saudi Arabia: Insulin Market: Share of Key Players (in 000 US$), 2005-2010
Table 4 4: Saudi Arabia: Insulin Market, Sales of Top Drugs (in 000 US$), 2005-2010
Table 4 5: Saudi Arabia: Oral Antidiabetics Market: Sales by Class (in 000 US$), 2005-2010
Table 4 6: Saudi Arabia: Oral Antidiabetics Market: Sales of Key Players (in 000 US$),
Table 4 7: Saudi Arabia: Oral Antidiabetics Market, Sales of Top Drugs (in 000 US$), 2005-2010
Table 4 8: Saudi Arabia: Oral Antidiabetics Market, New Drug Launches (2011-2016)
Table 4 9: Saudi Arabia: Oral Antidiabetics Market by Class Forecast, (in 000 US$), 2010, 2013 & 2016
IP VPN Market Forecast in Saudi Arabia to 2016 US$ 795.00 Apr, 2011 · 44 pages
Saudi Arabia Consumer Electronics Report Q1 2014 US$ 1,295.00 Jan, 2014 · 70 pages
Saudi Arabia Power Report Q4 2014 US$ 1,295.00 Oct, 2014 · 71 pages

Ask Your Question

Saudi Arabia Diabetes Market Report & Forecast 2011-2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: